Zika Virus Vaccine

A 70-year-old man from Gandhinagar city contracted Zika virus infection following which he was treated in a hospital and discharged, officials said on Thursday. While the report confirming that the man was infected with the Zika virus came four days ago, he was sent home from the hospital a week ago after full recovery, said the Gujarat Health Department in a statement. Zika virus is transmitted primarily by Aedes mosquitoes. The symptoms include rash, fever, conjunctivitis, muscle and joint pain. Zika infection during pregnancy can cause infants to be born with microcephaly and other congenital malformations as well as preterm birth and miscarriage. On October 24, the septuagenarian was admitted to a hospital in Gandhinagar after he had a cold, fever and joint pain. He was referred to an Ahmedabad-based private hospital, where doctors sent his body fluid samples to the National Institute of Virology (NIV) in Pune over the suspicion that it could be a case of Zika infection, said t

First-in-human trial is a type of clinical trial in which a new drug, procedure or treatment is tested in humans for the first time

Scientists have developed a simple-to-apply, needle-free vaccine patch that may protect people from the potentially deadly mosquito-borne Zika virus. The experimental vaccine developed by researchers at the University of Adelaide in Australia elicited an effective immune response to Zika virus in mice. The vaccine, described in the journal Molecular Therapy Nucleic Acids, uses the high-density microarray patch (HD-MAP) patch developed by the University of Queensland (UQ) in Australia for delivery. Zika virus is a risk to people across the Pacific, Southeast Asia, India, Africa and South and Central America. We can change the way we combat Zika virus with the HD-MAP patch because it is an effective, pain-free, simple to apply, and easy to store vaccination method, said Danushka Wijesundara, a researcher at The University of Queensland. HD-MAP delivers the vaccine to immune cells beneath the skin's surface with thousands of tiny microprojections," Wijesundara said. In the pre-clini

Test can differentiate between seven diseases and give results in 2 hrs

Covaxin was India's first indigenously developed vaccine to be approved, controversially under "clinical trial mode" in the first week of January

The application was on the Zika virus vaccine laiming 100% efficacy in animals for grant of permission to conduct the Phase-I clinical trial, Ashwini Choubey